392 related articles for article (PubMed ID: 18947412)
1. Effect of anti-CD52 antibody alemtuzumab on ex-vivo culture of umbilical cord blood stem cells.
Lim CK; Sun L; Feng Q; Law P; Chua WT; Lim SN; Hwang WY
J Hematol Oncol; 2008 Oct; 1():19. PubMed ID: 18947412
[TBL] [Abstract][Full Text] [Related]
2. Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored.
Ruggieri L; Heimfeld S; Broxmeyer HE
Blood Cells; 1994; 20(2-3):436-54. PubMed ID: 7538350
[TBL] [Abstract][Full Text] [Related]
3. [Effect of IL-6/sIL-6R on ex vivo expansion of human cord blood derived CD34+ cells].
Feng JF; Zhuang M; Zhu LJ; Sheng ZL; Zhu YQ; Li CP
Ai Zheng; 2004 Jun; 23(6):715-8. PubMed ID: 15191679
[TBL] [Abstract][Full Text] [Related]
4. The effect of different thawing methods, growth factor combinations and media on the ex vivo expansion of umbilical cord blood primitive and committed progenitors.
Kögler G; Callejas J; Sorg RV; Fischer J; Migliaccio AR; Wernet P
Bone Marrow Transplant; 1998 Feb; 21(3):233-41. PubMed ID: 9489645
[TBL] [Abstract][Full Text] [Related]
5. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.
Kobari L; Pflumio F; Giarratana M; Li X; Titeux M; Izac B; Leteurtre F; Coulombel L; Douay L
Exp Hematol; 2000 Dec; 28(12):1470-80. PubMed ID: 11146169
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells.
Traycoff CM; Abboud MR; Laver J; Brandt JE; Hoffman R; Law P; Ishizawa L; Srour EF
Exp Hematol; 1994 Feb; 22(2):215-22. PubMed ID: 7507862
[TBL] [Abstract][Full Text] [Related]
9. CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells.
Kobari L; Giarratana MC; Pflumio F; Izac B; Coulombel L; Douay L
J Hematother Stem Cell Res; 2001 Apr; 10(2):273-81. PubMed ID: 11359674
[TBL] [Abstract][Full Text] [Related]
10. An eight-fold ex vivo expansion of long-term culture-initiating cells from umbilical cord blood in stirred suspension cultures.
Kögler G; Callejas J; Sorg RV; Wernet P
Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S48-53. PubMed ID: 9712494
[TBL] [Abstract][Full Text] [Related]
11. IL-11 in combination with SLF and G-CSF or GM-CSF significantly increases expansion of isolated CD34+ cell population from cord blood vs. adult bone marrow.
van de Ven C; Ishizawa L; Law P; Cairo MS
Exp Hematol; 1995 Nov; 23(12):1289-95. PubMed ID: 7589284
[TBL] [Abstract][Full Text] [Related]
12. Ex vivo expansion of umbilical cord blood stem cells using different combinations of cytokines and stromal cells.
Madkaikar M; Ghosh K; Gupta M; Swaminathan S; Mohanty D
Acta Haematol; 2007; 118(3):153-9. PubMed ID: 17890847
[TBL] [Abstract][Full Text] [Related]
13. A human stromal-based serum-free culture system supports the ex vivo expansion/maintenance of bone marrow and cord blood hematopoietic stem/progenitor cells.
da Silva CL; Gonçalves R; Crapnell KB; Cabral JM; Zanjani ED; Almeida-Porada G
Exp Hematol; 2005 Jul; 33(7):828-35. PubMed ID: 15963859
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo expansion of stem cells: defining optimum conditions using various cytokines.
Mohamed AA; Ibrahim AM; El-Masry MW; Mansour IM; Khroshied MA; Gouda HM; Riad RM
Lab Hematol; 2006; 12(2):86-93. PubMed ID: 16751136
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous cord blood transplantation of ex vivo expanded together with non-expanded cells for high risk leukemia.
Kögler G; Nürnberger W; Fischer J; Niehues T; Somville T; Göbel U; Wernet P
Bone Marrow Transplant; 1999 Aug; 24(4):397-403. PubMed ID: 10467329
[TBL] [Abstract][Full Text] [Related]
16. Is in vitro expansion of human cord blood cells clinically relevant?
Denning-Kendall PA; Nicol A; Horsley H; Donaldson C; Bradley B; Hows JM
Bone Marrow Transplant; 1998 Feb; 21(3):225-32. PubMed ID: 9489644
[TBL] [Abstract][Full Text] [Related]
17. Short-term, serum-free, static culture of cord blood-derived CD34+ cells: effects of FLT3-L and MIP-1alpha on in vitro expansion of hematopoietic progenitor cells.
Capmany G; Querol S; Cancelas JA; García J
Haematologica; 1999 Aug; 84(8):675-82. PubMed ID: 10457401
[TBL] [Abstract][Full Text] [Related]
18. Cotransplantation of ex vivo expanded and unexpanded cord blood units in immunodeficient mice using insulin growth factor binding protein-2-augmented mesenchymal cell cocultures.
Ong LM; Fan X; Chu PP; Gay FP; Bari S; Ang JM; Li Z; Chen J; Lim SK; Bunte RM; Hwang WY
Biol Blood Marrow Transplant; 2012 May; 18(5):674-82. PubMed ID: 22240732
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the effect of cryopreservation on ex vivo expansion of hematopoietic progenitors from cord blood.
Lazzari L; Lucchi S; Montemurro T; Porretti L; Lopa R; Rebulla P; Sirchia G
Bone Marrow Transplant; 2001 Oct; 28(7):693-8. PubMed ID: 11704793
[TBL] [Abstract][Full Text] [Related]
20. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
